In Multiple sclerosis (MS) Multiple sclerosis (MS) is a disease of the brain and spinal cord in which a person’s own immune system attacks the protective sheath (called myelin) of the nerves. This leads to symptoms such as vision loss, pain, fatigue and improper coordination. Fingomod Capsule helps to suppress the body’s immune system, thereby reducing the progression of the disease. It reduces the inflammation of the damaged nerves, prevents further damage and stabilizes your immune system. It improves muscle strength and helps the patients to walk better. This makes the patients more confident and enhances their quality of life.
It is not known whether it is safe to consume alcohol with Fingomod Capsule. Please consult your doctor.
Fingomod Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Fingomod Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Fingomod Capsule does not usually affect your ability to drive.
Fingomod Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Fingomod Capsule may be needed. Please consult your doctor. For patients with mild and moderate kidney disease, Fingomod Capsule must be taken with proper consultation with the doctor.
Fingomod Capsule should be used with caution in patients with severe liver disease. Dose adjustment of Fingomod Capsule may be needed. Please consult your doctor. Fingomod Capsule is probably safe for patients with mild and moderate liver disease. However, proper consultation is advised before the initiation of the treatment.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
| QTY | Stock Status | Brand Name | Generic Name | Strength | Form | Size | MRP | Discount | Net Cost | MFR | Type | Add Cart |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Figo-MS Capsule | Fingolimod (0.5mg) | 0.5mg | Capsule | strip of 10 capsules | ₹890.00 | ₹890.00 | ₹0.00 | MSN... | RX |